Fig. 4From: Ustekinumab trough levels predicting laboratory and endoscopic remission in patients with Crohn’s diseaseComparison of endoscopic and clinical markers between bio-naïve patients (n = 12) and bio-switched patients (n = 16). The dashed line in AUA indicates the cutoff value to be judged as positive (0.27) [26]. UST, ustekinumab; AUA, anti-ustekinumab antibodies; CDAI, Crohn’s disease activity indexBack to article page